Annual report pursuant to Section 13 and 15(d)

Subsequent Events - Schedule of Proceeds From Initial Public Offering (Details)

v3.7.0.1
Subsequent Events - Schedule of Proceeds From Initial Public Offering (Details) - Subsequent Event [Member] - USD ($)
Mar. 31, 2017
Jan. 13, 2017
Gross Proceeds   $ 2,147,400
Payments of Stock Issuance Costs   208,350
Net Proceeds: $ 1,760,817 1,692,044
Underwriter And Gunnar Expenses [Member]    
Payments of Stock Issuance Costs 191,943 246,106
Underwriter And Gunnar Expenses [Member] | Underwriter Discount [Member]    
Payments of Stock Issuance Costs 141,943 150,318
Underwriter And Gunnar Expenses [Member] | Underwriter Legal Fees [Member]    
Payments of Stock Issuance Costs 50,000 60,000
Underwriter And Gunnar Expenses [Member] | Gunnar Roadshow [Member]    
Payments of Stock Issuance Costs   1,783
Underwriter And Gunnar Expenses [Member] | Gunnar Miscellaneoue [Member]    
Payments of Stock Issuance Costs   34,005
Akers Biosciences Expenses [Member]    
Payments of Stock Issuance Costs 75,000  
Akers Biosciences Expenses [Member] | Legal Accounting Expenses [Member]    
Payments of Stock Issuance Costs   197,813
Akers Biosciences Expenses [Member] | Registration Expenses [Member]    
Payments of Stock Issuance Costs   $ 11,437
Akers Biosciences Expenses [Member] | Legal Fees [Member]    
Payments of Stock Issuance Costs 75,000  
Common Shares [Member]    
Gross Proceeds $ 2,027,760  
Common Shares [Member] | Base Offering [Member]    
Number of common shares 1,448,400 1,667,000
Number of common shares, value $ 2,027,760 $ 122,500
Common Shares [Member] | Over-Allotment [Member]    
Number of common shares   2,000,400
Number of common shares, value   $ 147,000